Third line Follicular Lymphoma patients who are refractory to anti-CD20 based therapy
Multiple indications in metastatic breast cancer, early breast cancer and metastatic gastric cancer
Multiple indications in Non-Hodgkin's lymphoma (NHL), Chronic lymphocytic leukaemia (CLL), Rheumatoid arthritis, Granulomatosis with polyangiitis and microscopic polyangiitis and Pemphigus vulgaris